Saito, R., Kumabe, T., Mizusawa, J., Ishikawa, Y., Sasaki, K., Igaki, H., Sumi, M., Nakano, M., Kinoshita, M., Yamasaki, F., Komori, T., Shibuya, M., Sasaki, A., Ichimura, K., Shibahara, I., Kanamori, M., Mineharu, Y., Ohka, F., Arakawa, Y., Narita, Y. (2026). A multicenter randomized phase III study for newly diagnosed, maximally resected glioblastoma comparing carmustine wafer implantation followed by chemoradiotherapy with temozolomide versus chemoradiotherapy alone: Japan Clinical Oncology Group study JCOG1703 (MACS study).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2001